APREMEDA s.r.o

Company snapshot

Společnost Apremeda působí na českém a slovenském trhu a v souladu se strategií našeho obchodního partnera a výrobce Dr. Wolff Group pomáhá řešit mnohé tabuizované problémy jako je vypadávání vlasů, neurodermatitida nebo vaginální suchost. Apremeda ve spojení s Dr. Wolff Group přináší na český a slovenský trh značky ALPECIN, PLANTUR, LINOLA, VAGISAN, vybrané léčivé přípravky a zdravotnické prostře

• 5 active pipeline program(s) linked via ClinicalTrials.gov.
• 5 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for APREMEDA s.r.o. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for APREMEDA s.r.o.

1. Jun 8, 2026 Clinical update

   CPA 556-24 — Phase 1

2. Jun 8, 2026 Clinical update

   A pilot for UDCA causes a reduction in chol… — Phase 1

3. Jun 8, 2026 Clinical update

   01/2023/Pozlab — Phase 1

4. Jun 8, 2026 Clinical update

   204-PKT-202301 — Phase 1

5. May 26, 2026 Clinical update

   Midazolam 1 mg, Psilocybine 5 mg — Phase 2

View all clinical trial activity →

• What is APREMEDA s.r.o?

  s.r.o is a pharma organization headquartered in EU. Primary therapeutic focus areas include high blood pressure, increased blood clotting, Stable Ischemic Heart Disease. NovaPharmaNews links 5 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from publ

• Is APREMEDA s.r.o publicly traded?

  APREMEDA s.r.o appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does APREMEDA s.r.o develop or market?

  We link 16 drug profile(s) where APREMEDA s.r.o is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/s-r-o#company-drugs.

• What are the latest developments for APREMEDA s.r.o?

  In the last 12 months our linked public records show 5 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does APREMEDA s.r.o focus on?

  APREMEDA s.r.o focuses on high blood pressure, increased blood clotting, Stable Ischemic Heart Disease based on our analysis of their pipeline programs and drug development activities.